Format

Send to

Choose Destination
Best Pract Res Clin Obstet Gynaecol. 2012 Feb;26(1):149-60. doi: 10.1016/j.bpobgyn.2011.10.007. Epub 2011 Nov 25.

Management of haematological malignancy in pregnancy.

Author information

1
Haematology Department, Queen Elizabeth Hospital, Stadium Road, London, UK.

Abstract

The incidence of haematological malignancies in pregnancy ranges from 1 in 1000 to 1 in 10,000. International prospective epidemiology, management and outcome data are important to gain further knowledge of haematological malignancies in pregnancy. The management of haematological malignancies in pregnancy is complex and requires a multidisciplinary approach. The clinician and mother need to address both maternal and fetal well-being. The mother should be provided with the necessary information and support to make informed decisions regarding the pregnancy and disease management. The haematological malignancies are a diverse group with varied presenting features, pathophysiology, treatment options, levels of urgency to commence treatment in pregnancy, effect on maternal and fetal outcome and overall prognosis. We have reviewed the published research in this area, and provide concise up-to-date guidance on the management of haematological malignancies in pregnancy.

PMID:
22119057
DOI:
10.1016/j.bpobgyn.2011.10.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center